New GI, topical approaches target rosacea

[Guide]

Dr. Kanade Shinkai

An article in Skin and Allergy News in discussing Mirvaso states, "Stopping the medication did cause a kind of tachyphylaxis seen with other alpha-adrenergics used to treat nasal or conjunctival congestion, where stopping the drug increased erythema or edema." The article quotes Dr. Shinkai [above] as stating:

"I think the jury is still out" until more data become available on long-term use of brimonidine for erythema in rosacea. "However, I think this is a really exciting new development" because it adds to the few tools available for treatment, she said."

http://www.skinandallergynews.com/news/medical-dermatology/single-article/new-gi-topical-approaches-target-rosacea/5bed028c20a55b2c9e0d0a0a8a34d8d8.html